ITherapeutics ERUM Company Overview October 2019 Oral and IV treatment for serious bacterial infections ERUM 1 CONFIDENTIAL ITherapeutics Forward-looking Statements & Disclaimer This presentation contains forward-looking statements. These forward-looking statements include, without limitation, statements regarding the development, therapeutic and market potential of sulopenem, the sufficiency of cash resources, the granting or issuing of patents, the timing, progress and results of clinical trials, and the ...

ITherapeutics ERUM Company Overview August 2019 Oral and IV treatment for serious bacterial infections ERUM 1 CONFIDENTIAL ITherapeutics Forward-looking Statements & Disclaimer This presentation contains forward-looking statements. These forward-looking statements include, without limitation, statements regarding the development, therapeutic and market potential of sulopenem, the sufficiency of cash resources, the granting or issuing of patents, the timing, progress and results of clinical trials, and the e ...